12:00 AM
Mar 30, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Enzon, Santaris preclinical data

EZN-4187 dose-dependently reduced androgen receptor mRNA by up to 80% in the liver in vivo. The androgen receptor locked nucleic acid (LNA)...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >